Susan Barlett Phd And Clifton Bingham Md Discuss The Advantages Of Using The Promis Report

susan barlett phd and Clifton bingham md discuss the Ad
susan barlett phd and Clifton bingham md discuss the Ad

Susan Barlett Phd And Clifton Bingham Md Discuss The Ad Principal investigators: clifton o. bingham iii, md & susan bartlett, phd goal : to evaluate use of patient centered outcomes, assessed with the patient reported outcome measurement information system (promis), in clinical encounters of patients with rheumatoid arthritis, as a model for chronic diseases. Meet the experts. susan bartlett, phd and clifton bingham iii, md expertise: clinical implementation of promis in arthritis, score interpretation and use in clinical decision making and patient self management development. michael bass, ms expertise: pro software implementation. judy baumhauer, md, mph expertise: clinical interpretation.

Pdf Integrating promis In Arthritis Clinical Care вђ в Integrating
Pdf Integrating promis In Arthritis Clinical Care вђ в Integrating

Pdf Integrating Promis In Arthritis Clinical Care вђ в Integrating Ashley wilder smith. phd, mph, us national institutes of health, bethesda, md. betina yanez, phd, northwestern university, chicago, il. watch for dates for the 2023 promis training workshop. the promis 2022 training workshop offers an intensive learning experience on promis and how it is being used in clinical practice and research. About press copyright contact us creators advertise developers terms privacy policy & safety how works test new features nfl sunday ticket press copyright. Assessment working group (icoa wg); dr. clifton bingham p resented evidence from the observational research in which he and dr. susan bartlett a re assessing fatigue in ra. • drs. bingham and bartlett’s data suggests that in a subset of r a patients, fatigue is unique. And promis investigators, and with drs. bartlett and bingham to review the literature and gather clinical experts’ input to define fatigue and explore it s measurement in patients with mild to severe ra. • based on the work of kaiser and colleagues (2016), the promis® fatigue short form 10a was selected to move forward for qualification.

Comments are closed.